JAK2 and acquired polycythemia vera: In 2009, a study of a small cohort of PV JAK2 V617F mutated patients highlighted that 25% of erythroid precursors express elevated Bcl‐xL levels and its inhibition with ABT‐737 interferes with erythroid colonies formation.20